Ken Londoner is the founder of the privately held medical technology company BioSig Technologies, which works on researching and developing a new system that would treat more accurately patients suffering from Atrial Fibrillation and Complex Arrhythmia. Currently, the company is exploring the field’s applications across a variety of disease areas and disciplines, including neurology, auto-immune diseases, diabetes, arthritis, hypertension, pain management, cancer, and others. He founded the BioSig Technologies in 2009 and since then serves as a CEO and executive chairman.
Moreover, Ken Londoner Londoner is associated with Endicott Management Partners. This is another private investment company focused on medical technology and consumer-related companies, where he serves as Managing Partner. Prior to this, he served as Co-Founder and Member of Board of Directors at Safe Ports.
Londoner holds a holds a Bachelor’s degree in economics and finance from the Lafayette College in Easton, Pennsylvania and a Master’s degree from the NYU’s Stern School of Business with a dual major in finance and management.